Cocrystal Pharma’s Novel Norovirus Antiviral to be Presented at Department of Defense Medical Conference
Overview
2025 Annual Meeting of Stockholders
Stock Information
Nasdaq:
COCPPrice

Change

Mkt Cap

Volume

52 week Low/High

Day Low/High
